Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Rojymon Jacob M.D.
Professor
Close
E-mail
rjacob@uab.edu
Links
UAB Department of Radiation Oncology
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Rojymon Jacob M.D.
Professor
Positions
Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
Professor (P)
,
Radiation Oncology
,
School of Medicine
Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Scholar (C)
,
Center for Clinical and Translational Science (CCTS)
,
General Clinical Research Center
Publications
Research
Teaching
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2021
Hepatobiliary cancers, Version 2.2021
.
Journal of the National Comprehensive Cancer Network : JNCCN
. 19:541-565.
2021
2020
The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience.
.
Journal of Clinical Medicine Research
. 12:560-567.
2020
2020
The Novel Use of Stereotactic Radiotherapy for Remnant Adrenal Tissue in Nelson Syndrome
.
AACE Clinical Case Reports
. 6:e33-e36.
2020
2019
Repeat gamma knife stereotactic radiosurgery in the treatment of trigeminal neuralgia: A single-center experience and focused review of the literature
.
Journal of Clinical Neuroscience
. 70:102-107.
2019
2019
Feasibility of Dose Escalating [
18
F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
.
Advances in Radiation Oncology
. 4:649-658.
2019
2019
Therapeutic options for ampullary carcinomas. A review
.
Oncology Reviews
. 13:156-160.
2019
2019
Disparities in clinical outcomes across age, sex and race among patients with pancreatic adenocarcinoma: a single center experience
.
Annals of Oncology
. 30:iv64.
2019
2019
Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience
.
Annals of Oncology
. 30:iv74.
2019
2019
Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer
.
Annals of Oncology
. 30:iv67.
2019
2019
Recent advances in the systemic treatment of gastrointestinal malignancy
.
Indian Journal of Medical and Paediatric Oncology
. 40:336-340.
2019
2019
Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience
.
Annals of Oncology
. 30:iv89.
2019
2019
Hepatobiliary cancers, version 2.2019 featured updates to the NCCN guidelines
.
Journal of the National Comprehensive Cancer Network : JNCCN
. 17:302-310.
2019
2019
Advances in pancreatic cancer biomarkers
.
Oncology Reviews
. 13:69-76.
2019
2019
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial
.
Advances in Radiation Oncology
. 4:90-95.
2019
2017
Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer
.
Urologic Oncology: seminars and original investigations
. 35:663.e15-663.e21.
2017
2017
Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines
.
Journal of the National Comprehensive Cancer Network : JNCCN
. 15:563-573.
2017
2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
.
Journal of the National Comprehensive Cancer Network : JNCCN
. 15:563-573.
2017
2016
Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.
2016
2016
Improved postoperative survival for intraductal- growth subtype of intrahepatic cholangiocarcinoma
2016
2016
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma
2016
2016
Protocol RAD 0902: A Pilot Study of Transarterial Chemoembolization Followed by Stereotactic Radiation Therapy for Locally Advanced Hepatocellular Carcinoma.
2016
2016
Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy
.
Liver Transplantation
. 22:547-551.
2016
2016
Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies
.
World Journal of Gastroenterology
. 22:3006-3014.
2016
2016
Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinoma
.
Prostate Cancer
. 2016.
2016
2015
Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone
.
Journal of Gastrointestinal Cancer
. 46:149-155.
2015
2015
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm
2015
2015
Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinoma
.
Journal of Solid Tumors
. 5:59-68.
2015
2014
Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy
.
Urology
. 84:1383-1388.
2014
2014
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy
.
Radiation Oncology
. 9.
2014
2014
A technique using
99m
Tc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases
.
Medical Dosimetry
. 39:7-11.
2014
2014
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation
.
Urologic Oncology: seminars and original investigations
. 32:687-693.
2014
2013
Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer
.
Acta Oncologica
. 52:1181-1188.
2013
2013
Patient benefit from salvage radiation for prostate cancer.
.
Journal of Clinical Oncology
. 31:175.
2013
2013
Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy
.
Journal of Applied Clinical Medical Physics
. 14:4126.
2013
2013
Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy
.
Journal of Applied Clinical Medical Physics
. 14:64-71.
2013
2013
Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.
.
ISRN Oncology
. 2013:941269.
2013
2012
Radiation necrosis in the brain: Imaging features and differentiation from tumor recurrence
2012
2012
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.
.
Prostate Cancer
. 2012:546794.
2012
2011
Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.
.
Journal of Clinical Oncology
. 29:85.
2011
2010
The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: A case series
.
Endoscopy
. 42:423-425.
2010
2003
Yttrium90 synovectomy in the management of chronic knee arthritis: a single institution experience.
2003
2003
Case report: Squamous carcinoma in an oesophageal foregut cyst.
.
British Journal of Radiology
. 76:343-346.
2003
2002
Oligodendroglioma: clinical profile and treatment results.
.
Neurology India
. 50:462-466.
2002
2001
Haemangiopericytoma diagnosed from a metastasis 11years after surgery for "atypical meningioma".
.
British Journal of Radiology
. 74:856-858.
2001
2000
Profile of pediatric malignancies: a ten year study.
.
Indian Pediatrics
. 37:1234-1238.
2000
1999
60 Gy isodose volumes in carcinoma of the cervix and their relation to the geometry of uterine tube and ovoids.
.
British Journal of Radiology
. 72:168-172.
1999
1999
Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy.
.
Sarcoma
. 3:157-165.
1999
1998
Extragonadal germ-cell tumors: a ten-year experience.
1998
1998
Extraskeletal osteosarcoma of the orbit.
.
Sarcoma
. 2:121-124.
1998
1997
Radiotherapy in the treatment of verrucous carcinoma of the oral cavity.
.
Oral Oncology
. 33:124-128.
1997
1997
Primary malignant germ cell tumours of the mediastinum--results of multimodality treatment.
.
Acta Oncologica
. 36:317-321.
1997
1996
Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer.
.
Oral Oncology
. 32B:373-376.
1996
Research
Principal Investigator On
A Randomized Multi-Center Phase III Study of Individualized Sterotactic Body Radiation Therapy (SRBT) versus Trans-Arterial Chemoembolization (TACE) as a Bridge to Transplant in Hepatocellular Carcinoma
awarded by
LAHEY CLINIC, INC.
Investigator On
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer
awarded by
University of Florida^
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
NRG Oncology Member Institution Clinical Trial Fixed Price Subaward Agreement
awarded by
NRG ONCOLOGY FOUNDATION
ONE SHOT - Single Shot Radiotherapy for Localized Prostate Cancer - A Multicenter, Single Arm, Phase I/II Trial
awarded by
GENEVA UNIVERSITY HOSPITAL
Private Grant
awarded by
NEWLINK GENETICS, INC
Private Grant
awarded by
VARIAN MEDICAL SYSTEMS, INC.
Private Grant
awarded by
ELI LILLY AND COMPANY
RTOG Foundation Master Service Agreement for Participation in Foundation Research: RTOG 3501 Tryhard: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb) for Non-HPV Locally Advanced Head and Neck Cancer with Concurrent Chemoradiation
awarded by
American College of Radiology
UAB NRG Oncology Master Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
UAB NRG Oncology Member Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
UAB NRG Oncology Member Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
Teaching
Teaching Activities
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2014)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2015)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2015)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2016)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2016)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2017)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2017)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2018)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2018)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2018)
STP2161 - RADIATION ONCOLOGY MADE RIDICULOUSLY SIMPLE (Fall Term 2019)
STP29RO - STUDENT DESIGNED SPECIAL TOPIC IN RADIATION ONCOLOGY (Fall Term 2008)
Background
Education And Training
Regional Cancer Center, Residency
Royal Marsden Hospital NHS Trust, Residency
Velindre & Singleton NHS Trust, Residency
Velindre & Singleton NHS Trust, Residency
Fox Chase Cancer Center, Postdoctoral Fellowship
Fox Chase Cancer Center, PA, Postdoctoral Fellowship
Doctor of Medicine,
University of Kerala
1988
Contact
Full Name
Rojymon
Jacob